FDA Investigator Javier O Vega

Javier O Vega has conducted inspections on 44 sites in 15 countries as of 15 May 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
44
Last Inspection Date:
15 May 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Puerto Rico, Taiwan, Czechia, France, Italy, Argentina, Slovakia, Japan, India, Canada, China, Singapore, Belgium, Malta, Germany
FDA Investigators that have inspected at least one site in common with Javier O Vega:
Adalberto Cajigas, Adaliz Santaliz Cruz, Alberto A Viciedo, Alice S Tsao, Almaris N Alonso, An T Vu, Ann L Demarco, Annette Melendez, Anthony C Warchut, Ariel Cruz Figueroa, Arlene M Badillo, Atul J Agrawal, Azza Talaat, Barbara M Frazier, Bonita S Chester, Brandon C Heitmeier, Brenda Rivera, Brett R Havranek, Brian D Nicholson, Carl A Huffman, III, Carlos A Medina, Caroline Strasinger, CDR Ileana Barreto Pettit, Charanjeet Jassal, Charles I Ann, Charles M Edwards, Cheryl A Clausen, Christina A Miller, Christopher D Leach, Cody D Rickman, Constantin Y Philopoulos, Cynthia A Palmer, Darla J Christopher, Darren S Brown, Daryl A Dewoskin, David J Hafner, Dayna I Martinez, Debra J Bennett, Dell S Moller, Dennis Cantellops Paite, Dewayne E Whitlock, Dongping Dai, PhD, Douglas C Kovacs, Dr. Jason R Caballero, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Edwin Martinez, Elizabeth B Griffin, Emest F Bizjak, Eric M Mueller, PharmD, Eva I Merced Medina, Felix Maldonado, Frances L Dejesus, Gayle S Lawson, George J Flynn, Geraldine D Sanders, German Rivera, Gwyn G Dickinson, Hala L Selby, Harshal J Desai, Helen Verdel, Iraida Ortiz, Iris C Macinnes, Ivis L Negron, James A Beaulieu, James A Liubicich, James C Maclaughlin, James I Giefer, James P Mcreavey, James R Fleckenstein, Jamie L Dion, Jawaid Hamid, Jennifer A Quinones, Jennifer L Huntington, Jessica L Pressley, Joan M Cantellops Figueroa, Joel D Hustedt, Jogy George, Jorge E Martinez, Jorge L Guadalupe, Jorge L Lajara, Jose A Lopez, Jose Acruz Gonzalez, José E Meléndez, Jose Martinez, Jr, Jose Perez Soto, Jose R Hernandez, Jose R Lopez, Jose Velez, Joshua P Wireman, Juan Rjimenez Garcia, Junho Pak, Justin A Boyd, Kenneth G Klobus, Kenneth H Williams, Kenneth M Gordon, Kent C Faul, Kevin A Gonzalez, Kevin D Kallander, Kham Phommachanh, Kimberly Lewandowski Walker, Kristy A Zielny, Laiza V Garcia, Larry K Austin, Latorie S Jones, Laura E Garcia, Laurimer Kuilan Torres, Lawrence J Stringer, LCDR Debra Emerson, Libia M Lugo, Liming Zhang, Lindsey M Schwierjohann, Lloyd D Payne, Lourdes Andujar, LT Tamara J Henderson, Luis A Dasta, Marcellinus D Dordunoo, Marcus F Yambot, Maria Pkelly Doggett, MBA, Marian E Ramirez, Marianela Aponte Cruz, Marie A Fadden, Marilyn Santiago, Marisol Faberlle, Matt D Suedkamp, Matthew B Casale, Meisha R Sampson, Michael A Charles, Michael L Casner, Michael Levy, Michael P Sheehan, Michael R Goga, Michael R Klapal, Michael S Araneta, Michele L Obert, Michele Perry Williams, Michelle Yclark Stuart, Miguel A Martinez Perez, Milva E Melendez Perales, Min Tang, Mra Davism, Mra Greenc, Mra Mcculloughj, Muralidhara B Gavini, PhD, Myriam M Sosa, Nadeem I Chaudhry, Nancy A Saxenian Emmons, Nasir Ali, PhD, Nayan J Patel, Neal L Adams, Nicholas L Paulin, Noreen Muñiz, Pablo Feliciano, Pal S Mayasandra, Pankaj H Amin, Paraluman S Leonin, Parul M Patel, Patty P Kaewussdangkul, Paul L Bellamy, Qin Xu, Rajiv R Srivastava, Ramon A Hernandez, Raquel Gonzalez Rivera, Raymond T Oji, Reba A Gates, Rebeca M Melendez, Rebecca Parrilla, Rebecca Rodriguez, Regina T Brown, Richard E Needham, Richmond K Yip, Robert J Ham, Robert J Martin, Rodney G Raiford, Russell J Glapion, Saleem A Akhtar, Salvatore N Randazzo, Sandra A Hughes, Sangeeta M Khurana, PhD, Santos E Camara, Satheesh Thomas, Saundrea A Munroe, Seneca D Toms, Shirley H Isbill, Shirley J Berryman, Sina Shojaee, Sixto M Mercado Rios, Sri Ramakrishnaiah Yellela, PhD, Stacey S Degarmo, Stephanie D Crockett, Stephen J Mottola, Steven B Barber, Steven D Kehoe, Steven M Weinman, Steven P Donald, Susan D Yuscius, Susan M Jackson, Susan T Hadman, Susan W Ting, Syed N Ali, Tamil Arasu, PhD, Terri L Dodds, Thomas J Arista, Tiara Nbrown Crosen, Tonia F Bernard, Tracey L Harris, Tricia S Martinez, Unnee Ranjan, Uttaniti Limchumroon (Tom), Vioela J Caze, Vlada Matusovsky, Wanda J Torres, Wen Ning Chan (Sally), Yumi J Hiramine, Yvins Dezan, Zhongren Wu

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more